CVRx, Inc. (CVRX) stock

CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30

$0.61−0.02 (-3.60%)

Close on Nov 13, 2026Market cap $16.18MP/E –Yield –

CVRx operating margin

Operating margin is operating income as a percentage of revenue.

CVRx's operating margin for the twelve months ending Sep 30, 2026 was -81.9%. For fiscal 2025 it was -90.5%, against -116.0% the year before. The highest annual figure on record is -90.5% in fiscal 2025.

Annual operating margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-90.5%	+25.5
FY2024	Dec 31, 2024	-116.0%	−6.3
FY2023	Dec 31, 2023	-109.7%	+79.6
FY2022	Dec 31, 2022	-189.3%	+9.9
FY2021	Dec 31, 2021	-199.2%	−9.0
FY2020	Dec 31, 2020	-190.2%	–

Quarterly operating margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	-94.3%	−10.8
Q2 FY2026	Jun 30, 2026	-82.9%	+22.9
Q1 FY2026	Mar 31, 2026	-82.3%	+26.5
Q4 FY2025	Dec 31, 2025	-69.8%	−2.8
Q3 FY2025	Sep 30, 2025	-83.5%	+13.8
Q2 FY2025	Jun 30, 2025	-105.8%	+12.6
Q1 FY2025	Mar 31, 2025	-108.8%	+97.6
Q4 FY2024	Dec 31, 2024	-67.0%	+18.5
Q3 FY2024	Sep 30, 2024	-97.3%	−6.6
Q2 FY2024	Jun 30, 2024	-118.3%	+5.4
Q1 FY2024	Mar 31, 2024	-206.4%	−54.0
Q4 FY2023	Dec 31, 2023	-85.5%	+74.5
Q3 FY2023	Sep 30, 2023	-90.6%	+73.0
Q2 FY2023	Jun 30, 2023	-123.7%	+95.2
Q1 FY2023	Mar 31, 2023	-152.4%	+90.7
Q4 FY2022	Dec 31, 2022	-160.0%	+80.3
Q3 FY2022	Sep 30, 2022	-163.7%	+51.1
Q2 FY2022	Jun 30, 2022	-218.9%	−37.3
Q1 FY2022	Mar 31, 2022	-243.1%	−95.6
Q4 FY2021	Dec 31, 2021	-240.2%	−138.0
Q3 FY2021	Sep 30, 2021	-214.8%	+90.4
Q2 FY2021	Jun 30, 2021	-181.6%	+63.2
Q1 FY2021	Mar 31, 2021	-147.4%	–
Q4 FY2020	Dec 31, 2020	-102.3%	–
Q3 FY2020	Sep 30, 2020	-305.1%	–
Q2 FY2020	Jun 30, 2020	-244.8%	–